2017 MIPS Measure #443: Non-Recommended Cervical Cancer Screening in Adolescent Females

Valid Data Submission Method(s) Measure Type High Priority Measure? NQS Domain Specialty Measure Sets
Registry Process Yes Patient Safety Obstetrics/Gynecology, General Practice/Family Medicine

Measure Description

The percentage of adolescent females 16-20 years of age who were screened unnecessarily for cervical cancer

Instruction

This measure is to be reported once per performance period for female patients seen during the performance period. There is no diagnosis associated with this measure. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on services provided and the measure-specific denominator coding.

Denominator

Adolescent females 16-20 years of age with a visit during the measurement period

Denominator Criteria (Eligible Cases):
Patients aged 16-20 years of age on date of encounter
AND
Patient encounter during the performance period (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, G0402, G0438, G0439
AND NOT
DENOMINATOR EXCLUSIONS:
A history of cervical cancer, HIV, or immunodeficiency any time during the patient’s history through the end of the measurement period: C53.0, C53.1, C53.8, C53.9, D06.0, D06.1, D06.7, D06.9, Z85.41, D80.0, D80.1, D80.2, D80.3, D80.4, D80.5, D80.6, D80.7, D80.8, D80.9, D81.0, D81.1, D81.2, D81.4, D81.6, D81.7, D81.89, D81.9, D82.0, D82.1, D82.2, D82.3, D82.4, D82.8, D82.9, D83.0, D83.1, D83.2, D83.8, D83.9, D84.0, D84.1, D84.8, D84.9, D89.3, D89.810, D89.811, D89.812, D89.813, D89.82, D89.89, D89.9, B20, Z21, B97.35
OR
Patients who use hospice services any time during the measurement period: G9805

Numerator

Patients who received cervical cytology or an HPV test during the measurement period

Numerator Instructions:
INVERSE MEASURE – A lower calculated performance rate for this measure indicates better clinical care or control. The “Performance Not Met” numerator option for this measure is the representation of the better clinical quality or control. Reporting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control.

Numerator Options:
Performance Met: Patients who received cervical cytology or an HPV test (G9806)
OR
Performance Not Met: Patients who did not receive cervical cytology or an HPV test (G9807)

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.